AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
Today, Leap Therapeutics (LPTX.O) fell a dramatic 26.92%, far outpacing its typical daily volatility. The only technical signal that fired was the kdj death cross, which traditionally signals bearish momentum. Other reversal patterns such as head-and-shoulders, double top, and inverse head-and-shoulders did not trigger, meaning the drop isn’t tied to a clear trend reversal pattern. Instead, the bearish crossover suggests that short-term momentum is shifting decisively lower.
While no block trading data was available for
.O, the volume surged to 7,003,702 shares, which is abnormal for a stock with a current market cap of just $22.1 million. This suggests heavy selling pressure, especially as the stock traded down to its lowest price of the day. Without bid/ask clusters or inflow/outflow data, it's difficult to pinpoint the exact source of the sell-off, but the high volume points to significant institutional or algorithmic activity driving the move.LPTX.O belongs to a broader set of stocks in the health tech and biotech themes. While some stocks like AAP and BH also posted minor declines, others like ADNT and AXL were up, and AREB dropped more than 40%. This mixed performance across sector peers suggests the drop is likely stock-specific rather than a broader thematic sell-off. This is further supported by the fact that other small-cap biotech stocks did not experience similar declines.
Based on the above, two plausible explanations emerge:

Knowing stock market today at a glance

Dec.24 2025

Dec.24 2025

Dec.24 2025

Dec.24 2025

Dec.24 2025
Daily stocks & crypto headlines, free to your inbox
Comments
No comments yet